WO1994008551A3 - Pharmaceutical compositions and methods for treating cold symptoms - Google Patents
Pharmaceutical compositions and methods for treating cold symptoms Download PDFInfo
- Publication number
- WO1994008551A3 WO1994008551A3 PCT/US1993/008887 US9308887W WO9408551A3 WO 1994008551 A3 WO1994008551 A3 WO 1994008551A3 US 9308887 W US9308887 W US 9308887W WO 9408551 A3 WO9408551 A3 WO 9408551A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical compositions
- methods
- cold
- cold symptoms
- treating cold
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU49307/93A AU678561B2 (en) | 1992-10-09 | 1993-09-22 | Pharmaceutical compositions and methods for treating cold symptoms |
EP93921692A EP0662840A1 (en) | 1992-10-09 | 1993-09-22 | Pharmaceutical compositions and methods for treating cold symptoms |
CA002146637A CA2146637C (en) | 1992-10-09 | 1993-09-22 | Pharmaceutical compositions and methods for treating cold symptoms |
JP6510004A JPH08502288A (en) | 1992-10-09 | 1993-09-22 | Pharmaceutical composition and method for treating sensational symptoms |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95501392A | 1992-10-09 | 1992-10-09 | |
US07/955,013 | 1992-10-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994008551A2 WO1994008551A2 (en) | 1994-04-28 |
WO1994008551A3 true WO1994008551A3 (en) | 1994-06-23 |
Family
ID=25496254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/008887 WO1994008551A2 (en) | 1992-10-09 | 1993-09-22 | Pharmaceutical compositions and methods for treating cold symptoms |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0662840A1 (en) |
JP (1) | JPH08502288A (en) |
AU (1) | AU678561B2 (en) |
CA (1) | CA2146637C (en) |
MX (1) | MX9306295A (en) |
NZ (1) | NZ256346A (en) |
WO (1) | WO1994008551A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09500610A (en) * | 1993-04-30 | 1997-01-21 | ザ、プロクター、エンド、ギャンブル、カンパニー | Nasal fragrance releasing composition |
AU1716995A (en) * | 1994-03-18 | 1995-10-09 | Ciba-Geigy Ag | Aqueous solution of levocabastine for ophthalmic use |
US5698181A (en) * | 1994-12-09 | 1997-12-16 | Warner-Lambert Company | Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same |
US5626831A (en) * | 1995-12-20 | 1997-05-06 | Van Moerkerken; Arthur | Method for relief and prevention of common cold, and compositions |
US6469009B1 (en) | 1996-04-08 | 2002-10-22 | Ucb, S.A. | Pharmaceutical compositions for the treatment of rhinitis |
US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
US6013632A (en) * | 1997-01-13 | 2000-01-11 | Emory University | Compounds and their combinations for the treatment of influenza infection |
GB9707978D0 (en) * | 1997-04-21 | 1997-06-11 | Procter & Gamble | Throat soothing compositions |
GB9707977D0 (en) * | 1997-04-21 | 1997-06-11 | Procter & Gamble | Centre filled confectionery |
DE19814256A1 (en) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Solid, fast-breaking cetirizine formulations |
US6132758A (en) * | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
CA2459492A1 (en) * | 2001-09-04 | 2003-03-13 | Boehringer Ingelheim International Gmbh | Anti-influenzal agent |
DE60319685T2 (en) | 2002-04-04 | 2009-03-26 | Pfizer Products Inc., Groton | WELCOME COFFEE BAG |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US20090203776A1 (en) * | 2004-09-23 | 2009-08-13 | Matias Jonathan R | Methods of using menthol propyleneglycol-carbonate and analogs thereof for producing anti-inflammatory and anti-angiogenic effects |
US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
AU2016219620B2 (en) * | 2006-04-21 | 2017-05-11 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
WO2012104568A1 (en) * | 2011-02-02 | 2012-08-09 | GILHOLM, Stephen Philip | Compositions of monoterpenoids for stimulating the immune system |
AU2014306759B2 (en) | 2013-08-12 | 2018-04-26 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2016010771A1 (en) | 2014-07-17 | 2016-01-21 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
EP3209282A4 (en) | 2014-10-20 | 2018-05-23 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
MX2020012233A (en) | 2018-05-16 | 2021-01-29 | Bayer Healthcare Llc | High concentration suspension formulation for cold and flu soft gel capsule medications. |
CN112972439A (en) * | 2019-12-16 | 2021-06-18 | 南京亿华药业有限公司 | Yumei effervescent tablet and preparation method thereof |
US20210236430A1 (en) | 2020-02-03 | 2021-08-05 | Johnson & Johnson Consumer Inc. | Single layer chewable tablet comprising cetirizine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2127011A1 (en) * | 1971-02-04 | 1972-10-13 | Wilkinson Sword Ltd | |
WO1992017164A1 (en) * | 1991-04-04 | 1992-10-15 | The Procter & Gamble Company | Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5888334A (en) * | 1981-11-20 | 1983-05-26 | Takasago Corp | 3-l-menthoxypropane-1,2-diol |
-
1993
- 1993-09-22 EP EP93921692A patent/EP0662840A1/en not_active Withdrawn
- 1993-09-22 AU AU49307/93A patent/AU678561B2/en not_active Ceased
- 1993-09-22 CA CA002146637A patent/CA2146637C/en not_active Expired - Fee Related
- 1993-09-22 NZ NZ256346A patent/NZ256346A/en unknown
- 1993-09-22 JP JP6510004A patent/JPH08502288A/en active Pending
- 1993-09-22 WO PCT/US1993/008887 patent/WO1994008551A2/en not_active Application Discontinuation
- 1993-10-08 MX MX9306295A patent/MX9306295A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2127011A1 (en) * | 1971-02-04 | 1972-10-13 | Wilkinson Sword Ltd | |
WO1992017164A1 (en) * | 1991-04-04 | 1992-10-15 | The Procter & Gamble Company | Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
Also Published As
Publication number | Publication date |
---|---|
AU678561B2 (en) | 1997-06-05 |
WO1994008551A2 (en) | 1994-04-28 |
EP0662840A1 (en) | 1995-07-19 |
CA2146637C (en) | 2001-02-13 |
MX9306295A (en) | 1994-04-29 |
JPH08502288A (en) | 1996-03-12 |
AU4930793A (en) | 1994-05-09 |
NZ256346A (en) | 1997-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994008551A3 (en) | Pharmaceutical compositions and methods for treating cold symptoms | |
MX9605650A (en) | Fluticasone propionate formulations. | |
TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
DK0799024T3 (en) | Pharmaceutical aerosol containing at least one sugar | |
HUT60630A (en) | Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature | |
CA2125665A1 (en) | Medicaments | |
ATE292982T1 (en) | ANALGESIC SYNERGY THROUGH SIMULTANEOUS ADMINISTRATION OF SUBANALGESIC DOSES OF A MU-OPIOID ANAGONIST AND A KAPPA-2-OPIOID ANAGONIST | |
DE69533112D1 (en) | USE OF FLAVOLIGNANES FOR THE PRODUCTION OF MEDICINES WITH ANTIPROLIFERATIVE ACTIVITY IN UTERUS, BREAST, EGGS | |
SE9401406D0 (en) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
HK1003978A1 (en) | Composition for the treatment of schizophrenia | |
SG166294G (en) | Inhalation medicaments for treating respiratory disorders | |
GEP20002300B (en) | Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof | |
WO2003024387A3 (en) | Method and pharmaceutical composition for treating inflammation | |
DE4497905T1 (en) | Pharmaceutical composition for the prevention and treatment of motion sickness syndrome | |
HU9501964D0 (en) | Pharmaceutical composition for treating nicotine dependence | |
GR3015934T3 (en) | Reduction or prevention of skin irritation by drugs. | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
UA35611C2 (en) | Topical composition for inhibiting hair growth in mammals, method for application and topical composition for delivering water-soluble pharmaceutical to skin | |
UA32457C2 (en) | Drug (variants) and methods for exposure to drug | |
MY117918A (en) | Use of an h+, k+- atpase inhibitor in the treatment of nasal polyps | |
RU94040886A (en) | Use of melatonine derivatives for sleep disturbance treatment, pharmaceutical composition | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
EP0743068A3 (en) | Composition for inhibiting bone loss containing vanadyl sulfate | |
IL164317A0 (en) | Statin therapy for enhancing cognitive maintenance | |
ES2101311T3 (en) | USE OF A TRANSDERMIC DEVICE CONTAINING (E) -2- (P-FLUOROFENETIL) -3-FLUOROALILAMINA AND ITS USE FOR THE TREATMENT OF ALZHEIMER DISEASE. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA FI JP KR NO NZ RU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA FI JP KR NO NZ RU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 256346 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2146637 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993921692 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993921692 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993921692 Country of ref document: EP |